UnitedHealth Group (UNH) Upgraded to “Buy” at Citigroup

UnitedHealth Group (NYSE:UNH) was upgraded by research analysts at Citigroup from a “neutral” rating to a “buy” rating in a report released on Friday, The Fly reports.

A number of other equities research analysts also recently issued reports on UNH. Cleveland Research reissued a “buy” rating on shares of UnitedHealth Group in a report on Friday, January 11th. Stephens started coverage on shares of UnitedHealth Group in a report on Monday, January 14th. They issued an “overweight” rating and a $287.00 price target on the stock. Cantor Fitzgerald reissued a “buy” rating and issued a $310.00 price target on shares of UnitedHealth Group in a report on Tuesday, January 15th. Oppenheimer increased their price target on shares of UnitedHealth Group from $300.00 to $305.00 and gave the stock an “outperform” rating in a report on Wednesday, January 16th. Finally, Credit Suisse Group reissued a “buy” rating and issued a $310.00 price target on shares of UnitedHealth Group in a report on Friday, February 8th. One analyst has rated the stock with a sell rating, one has issued a hold rating, nineteen have given a buy rating and one has given a strong buy rating to the stock. UnitedHealth Group presently has an average rating of “Buy” and an average price target of $288.74.

Shares of UnitedHealth Group stock opened at $237.97 on Friday. UnitedHealth Group has a 12-month low of $208.07 and a 12-month high of $287.94. The stock has a market capitalization of $227.73 billion, a PE ratio of 18.48, a PEG ratio of 1.24 and a beta of 0.74. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.63.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $3.73 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.60 by $0.13. UnitedHealth Group had a net margin of 5.45% and a return on equity of 25.07%. The firm had revenue of $60.30 billion for the quarter, compared to the consensus estimate of $59.72 billion. During the same period in the prior year, the firm posted $3.04 earnings per share. The company’s revenue for the quarter was up 9.2% on a year-over-year basis. On average, analysts anticipate that UnitedHealth Group will post 14.7 earnings per share for the current year.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 2,930 shares of the stock in a transaction that occurred on Thursday, March 14th. The shares were sold at an average price of $253.39, for a total transaction of $742,432.70. Following the transaction, the director now directly owns 64,726 shares in the company, valued at $16,400,921.14. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Richard T. Burke sold 5,000 shares of the stock in a transaction that occurred on Tuesday, March 19th. The shares were sold at an average price of $257.32, for a total transaction of $1,286,600.00. Following the transaction, the director now owns 182,454 shares in the company, valued at $46,949,063.28. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 27,930 shares of company stock worth $6,746,683. 0.87% of the stock is owned by company insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of UNH. Crewe Advisors LLC bought a new position in UnitedHealth Group during the fourth quarter valued at approximately $25,000. Harvest Group Wealth Management LLC bought a new position in shares of UnitedHealth Group in the first quarter worth approximately $31,000. Pearl River Capital LLC bought a new position in shares of UnitedHealth Group in the fourth quarter worth approximately $35,000. Canton Hathaway LLC bought a new position in shares of UnitedHealth Group in the first quarter worth approximately $36,000. Finally, Ipswich Investment Management Co. Inc. bought a new position in shares of UnitedHealth Group in the fourth quarter worth approximately $40,000. Institutional investors and hedge funds own 87.49% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Further Reading: What is the strike price in options trading?

The Fly

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.